Contract Service Directory
Quotient Sciences
Company Headquarters
3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
Contract Service Directory
- 505(b)(2)
- Clinical Supply Management
- Clinical Trials Management
- Clinical Trials, Phase I
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Dosage Form Development
- Formulation Development
- Formulation Services
- Hot Melt Extrusion
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Preformulation
- Process Development/Scale-Up Services
Contract Services Directory
Content From Quotient Sciences
-
Free Webinar: Developing an Oral Modified Release (MR) Formulation
Challenges and Considerations for Achieving SuccessSponsored Content Released on 06.12.2020
-
Tufts CSDD Study on Accelerating Drug Development
Download this white paper to discover the time savings and financial benefits for drug developers that use Translational Pharmaceutics®.White Papers / Tech Papers Released on 01.06.2020
Related Content
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
ANA Therapeutics Partners with Quotient Sciences
Will manufacture ANA001 as a potential treatment for COVID-19.Contract Pharma Staff 08.13.20
-
Breaking News | Collaborations & Alliances | Industry News
Quotient Sciences, CytoAgents Form COVID-19 Collaboration
Expedites human clinical trials for COVID-19 drug candidateContract Pharma Staff 05.04.20
-
Tufts CSDD Study on Accelerating Drug Development
Download this white paper to discover the time savings and financial benefits for drug developers that use Translational Pharmaceutics®.
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News
Tufts Study Shows Translational Pharmaceutics Reduces Development Times
Can reduce development times by more than 12 months and lower R&D costs by more than $100 million per approved new drug.10.31.19
-
-
cGMP Manufacture | Formulation Development | Industry News
Permira Funds to Acquire Majority Stake in Quotient
Investment will support Quotient’s growth plans to expand formulation development and manufacturing capabilities07.18.19
-
Breaking News | cGMP Manufacture | Drug Development | Facilities | Formulation Development | Industry News
Quotient Sciences Invests $15M in New Facility
Constructs state-of-the-art early-phase formulation and manufacturing facility in U.S.10.16.18
-
cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development
Integrating CDMO and CRO Services
Mark Egerton explains the importance of integrating formulation development and adaptive manufacturing with clinical researchKristin Brooks, Managing Editor 09.04.18
-
Drug Development
Integrated Early-Stage Drug Development and Manufacturing
A key to accelerating the drug development process.Mark Egerton, Chief Executive Officer, Quotient Sciences 03.09.18
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | CRO News | Drug Development | Industry News
PPD, Quotient Sciences Form Pediatric Drug Pact
Aims to accelerate pediatric drug development by shortening timelines, reducing costs and simplifying contracting processes01.16.18
-
Drug Development
Photos from the 2017 AAPS Annual Meeting
The show floor exhibition, Quotient unveiling, and Steer Life product premier11.21.17
-
Breaking News | Industry News
-
Breaking News | Industry News
Quotient Sciences Acquires CDMO Pharmaterials
The move further expands Quotient’s footprint in the U.K.11.14.17
-
cGMP Manufacture | Clinical Trial Materials | Drug Development | Formulation Development | Industry News
Quotient Clinical Launches New Identity
New identity depicts extended range of services following acquisitions of Co-Formulate, QS Pharma and SeaView Research11.10.17
